PubRank

E J Field

Author PubWeight™ 163.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lymphocyte sensitisation: an in-vitro test for cancer? Lancet 1970 8.23
2 Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J 1971 5.53
3 Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet 1970 2.73
4 Zika virus infection of the central nervous system of mice. Arch Gesamte Virusforsch 1971 2.63
5 Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer 1972 2.46
6 Sensitization of blood lymphocytes to possible antigens in neurological disease. Eur Neurol 1970 2.19
7 The connexions of the spinal sub-arachnoid space with the lymphatic system. J Anat 1948 2.18
8 Specific laboratory test for diagnosis of multiple sclerosis. Br Med J 1974 2.17
9 Electron microscopic observations on the cerebellar cortex in kuru. J Neurol Sci 1969 2.14
10 Demonstration of sensitized lymphocytes in blood. J Clin Pathol 1971 2.04
11 Letter: A rational prophylactic therapy for multiple sclerosis? Lancet 1973 1.97
12 Unsaturated fatty acids in multiple sclerosis. Br Med J 1973 1.75
13 Platelet stickiness in multiple sclerosis. Lancet 1965 1.58
14 The infective process in scrapie. Lancet 1968 1.56
15 Transmission experiments with multiple sclerosis: an interim report. Br Med J 1966 1.51
16 Darwin's illness. Lancet 1990 1.49
17 The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics. Clin Exp Immunol 1973 1.49
18 Viruses in multiple sclerosis? Lancet 1972 1.48
19 "Spontaneous" lymphocyte reactivity in the presence of virus infection. Lancet 1972 1.48
20 Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet 1968 1.46
21 An electron-microscopic study of scrapie in the rat: further observations on "inclusion bodies" and virus-like particles. J Neurol Sci 1972 1.45
22 Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol 1968 1.41
23 Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds. Nature 1971 1.41
24 Lymphocyte sensitization in sarcoidosis. Br Med J 1971 1.39
25 Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet 1968 1.36
26 A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer 1973 1.34
27 Lymphocyte transformation in the Guillain-Barré syndrome. Lancet 1969 1.29
28 Experimental allergic encephalomyelitis. An electron microscopic study. Am J Pathol 1966 1.28
29 Localization of tumour specific antigen on external surface of plasma membrane. Nat New Biol 1972 1.25
30 Isolation of an "antigen" from malignant tumours. Br J Cancer Suppl 1973 1.24
31 Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation. Br J Cancer Suppl 1973 1.21
32 Immunosuppression with polyunsaturated fatty acids in renal transplantation. Transplantation 1977 1.18
33 Paramyxovirus like tubules in multiple sclerosis biopsy material. Acta Neuropathol 1973 1.17
34 Is maternal lymphocyte sensitisation passed to the child? Lancet 1971 1.16
35 Effect of prolonged ingestion of gamma-linolenate by MS patients. Eur Neurol 1978 1.16
36 On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis. Clin Exp Immunol 1970 1.15
37 Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl 1973 1.15
38 Slow virus infections of the nervous system. Int Rev Exp Pathol 1969 1.15
39 Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease. J Neurol 1977 1.14
40 Immunodiagnosis of cancer. Br Med J 1972 1.13
41 Anti-macrophage component of antilymphocytic serum. Lancet 1969 1.12
42 Scrapie in the rat: an electron-microscopic study. II. Glial inclusions. Acta Neuropathol 1967 1.11
43 gamma-Linolenate in multiple schlerosis. Lancet 1978 1.10
44 Antibodies to measles antigen, control antigen, and monkey kidney antigen. Studies in patients with multiple sclerosis and other neurological diseases and normal healthy individuals. Neurology 1969 1.10
45 Inhibitory effect of unsaturated fatty acids on lymphocyte-antigen interaction with special reference to multiple sclerosis. Acta Neurol Scand 1975 1.09
46 Toxicity of motor neurone disease serum for myelin in tissue culture. Br Med J 1965 1.09
47 Immune responses in pregnancy. Lancet 1972 1.07
48 Sensitized lymphocytes in muscular dystrophy: evidence for a neural factor in pathogenesis. J Neurol Neurosurg Psychiatry 1971 1.05
49 Lymphocyte response depressive factor in multiple sclerosis. Br Med J 1971 1.05
50 Red blood cell fragility in multiple sclerosis. Br Med J 1967 1.05
51 Scrapie in the rat: an electron-microscope study. I. Amyloid bodies and deposits. Acta Neuropathol 1967 1.04
52 Mode of action of antilymphocyte serum. Lancet 1969 1.02
53 Measles, multiple sclerosis, and encephalitogenic factor. Lancet 1972 1.01
54 M.E.M. test for malignant disease. Lancet 1972 1.01
55 Nuclear structures in nerve cells in multiple sclerosis. Brain Res 1968 0.99
56 The incorporation of (3H) thymidine and (14C) glucosamine into a DNA-polysaccharide complex in normal and scrapie-affected mouse brain. Arch Gesamte Virusforsch 1970 0.98
57 Experimental allergic encephalomyelitis in the rhesus monkey. An electron microscopic study. J Neurol Sci 1969 0.96
58 Lymphocyte reactivity to antigen in pregnancy. Am J Obstet Gynecol 1972 0.96
59 Interaction of hallucinogenic drugs with encephalitogenic protein of myelin. Nature 1972 0.95
60 Lymphocyte sensitization to nervous tissues and muscle in patients with the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1971 0.95
61 Identification of a tumour antigen. Biochem J 1972 0.95
62 Delayed hypersensitivity studies: some applications of cell electrophoresis. J R Coll Physicians Lond 1972 0.93
63 Influenzal encephalitis in mice. A histopathological and electron microscopical study. Arch Gesamte Virusforsch 1971 0.93
64 Lymphocyte sensitization after exposure to measles, and influenza. Possible relevance to pathogenesis of multiple sclerosis. J Neurol Sci 1973 0.93
65 Effect of gamma-linolenate in multiple sclerosis. Lancet 1976 0.92
66 Electron microscopic observations on the development of myelin in cultures of neonatal rat cerebellum. J Neurol Sci 1969 0.92
67 Susceptibility of scrapie agent to ionizing radiation. Nature 1969 0.91
68 Intranuclear inclusions in neurones and glia: a study in the ageing mouse. Gerontologia 1971 0.91
69 Brain damage and emotional behaviour: the effects of scrapie on the emotional responses of mice. Anim Behav 1965 0.91
70 Lymphocyte reactivity in cancer. Lancet 1971 0.91
71 Measles virus associated with an unusual subacute encephalitis in an infant. J Neurol Sci 1972 0.90
72 Anomalous lymphocyte-antigen reaction in relatives of multiple sclerosis patients. A study of a possible genetic factor in the disease. J Neurol 1977 0.90
73 Letter: Effect of polyunsaturated fatty acids on lymphocyte activity. Br Med J 1973 0.90
74 Inhibition of macrophage migration in vitro by brain and encephalitogenic factor in allergic encephalomyelitis. Int Arch Allergy Appl Immunol 1968 0.90
75 Immunological study of chronic polyneuropathies of undetermined cause. J Neurol Neurosurg Psychiatry 1966 0.89
76 Antilymphocytic serum in experimental allergic encephalomyelitis. Br Med J 1969 0.88
77 Lymphocyte sensitization in asthma with special reference to nature and identity of intrinsic form. Br Med J 1973 0.88
78 Inhibition of lymphocyte response by serum. Lancet 1971 0.88
79 Failure of interferon to modify scrapie in the mouse. J Gen Virol 1969 0.88
80 Origin of red-cell-membrane differences in multiple sclerosis. Lancet 1979 0.87
81 Screening of children at risk of multiple sclerosis. Lancet 1977 0.86
82 A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests. J Immunol Methods 1977 0.86
83 Orientated tubules in axoplasm of cerebellar myelinated nerve fibres in the rat. A study of normal and scrapie animals. Acta Neuropathol 1967 0.85
84 Letter: Diagnostic test for multiple sclerosis. Br Med J 1974 0.85
85 Myelotoxicity of serum and spinal fluid in multiple sclerosis: a critical assessment. Clin Exp Immunol 1967 0.85
86 Observations on "dense-body" structure in nerve cells with special reference to scrapie. Res Vet Sci 1966 0.84
87 Polyunsaturated fatty acids in multiple sclerosis. Br Med J 1979 0.84
88 Rapid development of a cancer-like antigen in normal tissue in vitro. Br J Cancer 1973 0.84
89 Lymphocyte sensitization and ageing. Gerontologia 1972 0.83
90 Stress effect of antilymphocyte serum. Br Med J 1969 0.83
91 Lymphocyte sensitisation in myasthenia gravis: function of the adult thymus gland. Lancet 1973 0.83
92 Lymphocyte stimulation with phytohaemagglutinin in multiple sclerosis. Lancet 1969 0.82
93 Some observations on the role of circulating antibody in protection against experimental allergic encephalomyelitis. Z Immunitatsforsch Allerg Klin Immunol 1966 0.82
94 Axonal flow and myelin protein in the optic pathway. Nat New Biol 1973 0.82
95 The incorporation of [3H]thymidine, [14C]orotic acid, [14C]uridine-diphosphoglucose and [14C]glucosamine into a post-ribosomal fraction of normal and scrapie-affected mouse brain and spleen. J Gen Virol 1969 0.81
96 Role of viral infection and autoimmunity in aetiology and pathogenesis of multiple sclerosis. Lancet 1973 0.81
97 An electron-microscopic study of multiple sclerosis biopsy material: some unusual inclusions. J Neurol Sci 1973 0.80
98 Lymphocyte sensitization. Br Med J 1971 0.80
99 Letter: Effect of viruses on lymphocyte reactivity. Br Med J 1974 0.80
100 Distribution of 14C-labelled encephalitogenic factor after intracutaneous inoculation. J Neurol Sci 1970 0.80
101 Cyclophosphamide inhibition of experimental allergic encephalomyelitis in guinea pigs. Arch Int Pharmacodyn Ther 1969 0.79
102 Failure to induce myelin sheath formation around artificial fibres with a note on the toxicity of polyester fibres for nervous tissue in vitrol. J Neurol Sci 1969 0.79
103 Measles and multiple sclerosis. Lancet 1973 0.79
104 Scrapie: a review of its relation to human disease and ageing. J Med Genet 1976 0.79
105 The immunological diagnosis of human malignant disease. Ann Clin Biochem 1976 0.79
106 Rickettsial antibodies in multiple sclerosis. Br Med J 1970 0.79
107 Relation of measles virus to encephalitogenic factor with reference to the aetiopathogenesis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1974 0.79
108 Periodate--an inhibitor of the scrapie agent? Res Vet Sci 1972 0.79
109 Lymphocyte sensitization to carcinoembryonic antigen (Gold) with special reference to multiple sclerosis. Br Med J 1972 0.78
110 Influenzal encephalitis in mice. A further electron microscopic study. Arch Gesamte Virusforsch 1973 0.78
111 Cellular sensitization in kuru, Jakob-Creutzfeldt disease and multiple sclerosis: with a note on the biohazards of slow infection work. Acta Neurol Scand 1975 0.77
112 Invasion of the nervous system by "slow" virus: a study with scrapie agent. Int Arch Allergy Appl Immunol 1969 0.77
113 Inhibition of apolipoprotein B secretion by IL-6 is mediated by EGF or an EGF-like molecule in CaCo-2 cells. J Lipid Res 1997 0.77
114 Storage of lymphocytes for immunological study. J Clin Pathol 1972 0.77
115 Lymphocyte sensitisation in cancer. Lancet 1971 0.77
116 The macrophage electrophoretic mobility test (MEM) some technical considerations. J Immunol Methods 1975 0.77
117 An unusual structure in Kuru brain. Acta Neuropathol 1970 0.77
118 Altered response to scrapie tissues in neurological disease. Possible evidence for an antigen associated with reactive astrocytes. Brain 1973 0.76
119 Further observations with the erythrocyte-unsaturated fatty acid test. A contribution to the genetics of multiple sclerosis. Eur Neurol 1980 0.76
120 Action of an alcoholic solution of iodine on the scrapie agent. Res Vet Sci 1972 0.76
121 Sodium and potassium in scrapie brain. Res Vet Sci 1966 0.76
122 Emergence of new antigens in ageing tissues. Gerontologia 1973 0.76
123 Invasion of the mouse nervous system by scrapie agent. Br J Exp Pathol 1967 0.76
124 Transmission of kuru to mice. Lancet 1968 0.76
125 Amyloidosis, Alzheimer's disease, and ageing. Lancet 1970 0.76
126 Viral properties of scrapie. Nat New Biol 1971 0.76
127 Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids. Eur Neurol 1983 0.76
128 Lymphocyte sensitization to basic protein of brain in multiple sclerosis and other neurological diseases. J Neurol Neurosurg Psychiatry 1974 0.75
129 Multiple sclerosis or blood-brain barrier disease. Lancet 1989 0.75
130 Structural changes in scrapieaffected brain. Biochem J 1969 0.75
131 A rapid immunologic test for scrapie in sheep. Am J Vet Res 1974 0.75
132 Rapid diagnosis of scrapie in the mouse. Nature 1972 0.75
133 Multiple sclerosis--virological considerations, together with a note on the passage of Kuru. Proc R Soc Med 1968 0.75
134 Multiple sclerosis: relation to scrapie and slow infection; ageing and measles. Acta Neurol Scand 1975 0.75
135 Lactic dehydrogenase isoenzymes in normal and pathological spinal fluids. J Clin Pathol 1965 0.75
136 Evidence against transmission of scrapie by animal house fomites. Nature 1970 0.75
137 Immunological reactions in scrapie: the basis of a rapid titration method. Pathol Biol (Paris) 1973 0.75
138 Failure of the scrapie agent to replicate in L5178Y mouse leukaemic cells. Res Vet Sci 1972 0.75
139 Neuroglia and the myelin-bearing cell: a symposium. Pathogenesis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1969 0.75
140 Multiple sclerosis: what can and cannot be done. Br Med J 1980 0.75
141 Lymphocyte sensitization to thymus and lymph node antigen in multiple sclerosis and other neurological diseases. J Neurol Neurosurg Psychiatry 1973 0.75
142 Letter: Linoleic acid in multiple sclerosis. Br Med J 1975 0.75
143 Multiple sclerosis: what can and cannot be done. Br Med J 1979 0.75
144 Stability of radioiodinated encephalitogenic factor in vivo. Clin Exp Immunol 1968 0.75
145 Electrophoretic slowing of senstized lymphocyte-macrophage mixtures: a cellular technique in immunochemistry. Biochem J 1972 0.75
146 Multiple sclerosis: treatment and prophylaxis. J R Soc Med 1979 0.75
147 The assessment of histocompatibility by mixed lymphocyte reaction as measured by the macrophage electrophoretic mobility (MEM) test. Tissue Antigens 1975 0.75
148 Immunoglobulin receptors on "T" lymphocyte surface. Z Immunitatsforsch Exp Klin Immunol 1974 0.75
149 Letter: Lymphocyte response to paramyxovirus antigens in multiple sclerosis. Lancet 1976 0.75
150 A comparison of toxicity of serum from multiple sclerosis and motor neurone disease on myelin in vitro. Int Arch Allergy Appl Immunol 1969 0.75
151 Letter: Assay of thymosin in blood. Lancet 1975 0.75
152 Effect of imuran (azathioprine) on susceptibility of guinea pigs to allergic encephalomyelitis. Arch Int Pharmacodyn Ther 1967 0.75
153 Demyelinative lesions in spinal cord of mouse following neonatal thymectomy. An electron microscopic study. Z Neurol 1970 0.75
154 Multiple sclerosis: a rejoinder. Practitioner 1983 0.75
155 Immunological assessment of ageing: emergence of scrapie-like antigens. Age Ageing 1978 0.75
156 Rapid immunological method for diagnosis of natural scrapie in sheep. Nature 1973 0.75
157 The thymus gland: recent studies relating to 'thymosin', ageing and 'slow' infection of the nervous system. J R Coll Physicians Lond 1977 0.75
158 Assay for sensitized lymphocytes. N Engl J Med 1971 0.75
159 Central nervous system disease in neonatally thymectomized mice. Dtsch Z Nervenheilkd 1970 0.75
160 Lack of anti-macrophage species specificity in anti-lymphocytic serum. Nat New Biol 1971 0.75
161 Clinical and pathological findings in kuru. Lancet 1969 0.75
162 Delayed hypersensitivity studies in experimental allergic encephalomyelitis; a comparison of macrophage migration inhibition tests and electrophoretic mobility. Z Immunitatsforsch Exp Klin Immunol 1970 0.75
163 Simplified E-UFA test for multiple sclerosis (MS): some sources of "false" results. J Neurol 1981 0.75
164 Scrapie-like antigen(s) in ageing tissues. Nature 1973 0.75
165 Central nervous system disease in neonatally thymectomized mice. Dtsch Z Nervenheilkd 1969 0.75
166 Lattice fibrillar or herringbone structures in kuru. Vet Rec 1967 0.75
167 Letter: Unsaturated fatty acids and cellular immunity. Lancet 1975 0.75
168 Letter: Inhibition of lymphocyte response to stimulants by unsaturated fatty acids and prostaglandins. Lancet 1974 0.75
169 Mixed lymphocyte reaction in multiple sclerosis. Acta Neurol Scand 1976 0.75
170 Glial cell inclusion bodies in a case of acute disseminated sclerosis. Acta Neurol Scand 1966 0.75
171 Letter: Aetiopathogenesis of multiple sclerosis. Lancet 1974 0.75
172 Ribosome-like particles in cerebrospinal fluid. Dtsch Z Nervenheilkd 1969 0.75
173 Multiple sclerosis and measles: a study of cellular sensitization. Eur Neurol 1976 0.75
174 Laboratory tests in multiple sclerosis. Lancet 1979 0.75
175 Metabolism of polyamines in normal and scrapie-affected mouse brain and spleen. J Neurochem 1972 0.75
176 Nonspecies specificity of antilymphocyte serum. Transplantation 1971 0.75
177 A study of body, adrenal and pituitary weight changes in mouse scrapie with a note on neurosecretory activity. Res Vet Sci 1969 0.75
178 Use of plasma for immediate diagnosis of multiple sclerosis (plasma-erythrocyte unsaturated fatty acid test): comparison with the erythrocyte-unsaturated fatty acid (E-UFA) test. Neurol Res 1986 0.75
179 Virus-like bodies associated with spontaneous lung neoplasm in a mouse. Beitr Pathol Anat 1967 0.75
180 [Method of electrophoretic mobility of macrophages and its use in clinical immunology]. Zh Mikrobiol Epidemiol Immunobiol 1978 0.75
181 Letter: Macrophage electrophoretic mobility test. Lancet 1976 0.75
182 Thymectomy and immunological ageing in mice: precocious emergence of scrapie-like antigen. Gerontologia 1973 0.75
183 Letter: Brain and thymus antigens. Lancet 1974 0.75
184 Treatment of cancer by alteration of a cancer specific surface membrane epitope. Med Hypotheses 1986 0.75
185 Neurological illness after inoculation of tissue from tumour bearing animals. Nature 1969 0.75
186 A plasma lactic dehydrogenase-elevating virus associated with scrapie-infected mice. J Gen Virol 1967 0.75
187 The diagnostic problem in multiple sclerosis (M.S.): two specific laboratory tests. Boll Ist Sieroter Milan 1978 0.75
188 Multiple sclerosis and family therapy. Practitioner 1988 0.75
189 Letter: Linoleic acid and transplantation. Lancet 1975 0.75
190 Scrapie agent and neurones. Nature 1972 0.75
191 Riley virus in wild mice. Lancet 1968 0.75
192 Letter: Unsaturated fatty acids and transplantation. Lancet 1975 0.75
193 Letter: Simplified laboratory test for multiple sclerosis. Lancet 1976 0.75
194 Letter: Unsaturated fatty acids and renal transplantation. Lancet 1974 0.75
195 [Remarks to the paper of H. Meyer-Rienecker, H.-L. Jenssen, H. Köhler, J. Günther und H. J. Gundlach: Utilization and significance of the macrophages-electrophoresis-mobility (MEM)-test in neurologic diseases]. Klin Wochenschr 1974 0.75